Results 81 to 90 of about 3,764 (237)

Impact of a malaria intervention package in schools on Plasmodium infection, anaemia and cognitive function in schoolchildren in Mali: a pragmatic cluster-randomised trial. [PDF]

, 2017
BACKGROUND: School-aged children are rarely targeted by malaria control programmes, yet the prevalence of Plasmodium infection in primary school children often exceeds that seen in younger children and could affect haemoglobin concentration and school ...
Bamadio, Modibo, Brooker, Simon, Clarke, Siân E, Diarra, Seybou, Jones, Rebecca, Jukes, Matthew Ch, Roschnik, Natalie, Rouhani, Saba, Sacko, Moussa, Saye, Renion, Thuilliez, Josselin, Traore, Diahara, Traore, Klenon   +12 more
core   +3 more sources

Micronutrient Powders Combined With Malaria Chemoprevention to Improve Anaemia and Cognitive Function in Early Childhood in Mali: A Cluster‐Randomised Trial

Maternal &Child Nutrition, Volume 21, Issue 4, October 2025.
Globally nearly 40% of children under 5 years old are anaemic, which affects their ability to grow and develop. A cluster randomised trial was conducted in 60 communities in Southern Mali to evaluate the added impact of home fortification with micronutrient powders, delivered alongside seasonal malaria chemoprevention, on anaemia, malaria infection ...
Niélé H. Diarra, Yahia Dicko, Natalie Roschnik, Modibo Bamadio, Michael Boivin, Yvonne Griffiths, Rebecca Jones, Sham Lal, Helen Moestue, Hamidou Niangaly, Lauren Pisani, Renion Saye, Kalifa Sidibe, Karla Smuts, Nia‐An Philippe Thera, Josselin Thuilliez, Hans Verhoef, Moussa Sacko, Siân E. Clarke   +18 more
wiley   +1 more source

Review of contextual factors related to seasonal malaria chemoprevention

, 2022
Report considered by the WHO/GMP Guideline Development Group on Malaria Chemoprevention for “Section 4.2.3 Seasonal malaria chemoprevention (SMC)” of the WHO Guidelines for malaria, 3 June 2022.
Bhattarai A, Thwing J, Williamson J, Cavros I, Gutman J   +4 more
openaire   +1 more source

Facilitators and barriers to seasonal malaria chemoprevention (SMC) uptake in Nigeria: a qualitative approach

Malaria Journal, 2023
Abstract Background SMC was adopted in Nigeria in 2014 and by 2021 was being implemented in 18 states, over four months between June and October by 143000 community drug distributors (CDDs) to a target population of 23million children.
Nnenna Ogbulafor, Perpetua Uhomoibhi, Emmanuel Shekarau, Jamilu Nikau, Chukwu Okoronkwo, Nadia M. L. Fanou, Ibrahima Marietou Mbaye, Jean-Louis Ndiaye, Andre-Marie Tchouatieu, Abena Poku-Awuku, Corinne Merle, Susana Scott, Paul Milligan, Aminu Ali, Hauwa’u Evelyn Yusuf, Stephen Oguche, Tukur Dahiru   +16 more
openaire   +3 more sources

Tools and Strategies for Malaria Control and Elimination: What Do We Need to Achieve a Grand Convergence in Malaria? [PDF]

, 2016
Progress made in malaria control during the past decade has prompted increasing global dialogue on malaria elimination and eradication. The product development pipeline for malaria has never been stronger, with promising new tools to detect, treat, and ...
Achee, Nicole, Bell, David, Djimdé, Abdoulaye A., Hemingway, Janet, Qi, Gao, Shretta, Rima, Wells, Timothy N. C.   +6 more
core   +3 more sources

Opportunities and Challenges of Population Pharmacogenomics

Annals of Human Genetics, Volume 89, Issue 5, Page 384-397, September 2025.
ABSTRACT Pharmacological responses can vary significantly among patients from different ethnogeographic backgrounds. This variability can, at least in part, be attributed to population‐specific genetic patterns in genes involved in drug absorption, distribution, metabolism, and excretion, as well as in genes associated with drug‐induced toxicity ...
Yitian Zhou, Yoomi Park, Mahamadou D. Camara, Volker M. Lauschke   +3 more
wiley   +1 more source

Use of population pharmacokinetic‐pharmacodynamic modelling to inform antimalarial dose optimization in infants

British Journal of Clinical Pharmacology, Volume 91, Issue 4, Page 968-980, April 2025.
Infants bear a significant malaria burden but are usually excluded from participating in early dose optimization studies that inform dosing regimens of antimalarial therapy. Unlike older children, infants' exclusion from early‐phase trials has resulted in limited evidence to guide accurate dosing of antimalarial treatment for uncomplicated malaria or ...
Clifford G. Banda, Joel Tarning, Karen I. Barnes   +2 more
wiley   +1 more source

Sub-National Targeting of Seasonal Malaria Chemoprevention in the Sahelian Countries of the Nouakchott Initiative [PDF]

PLOS ONE, 2015
Antecedentes Se ha demostrado que la quimioprevención estacional de la malaria (SMC) es altamente eficaz contra la malaria clínica en áreas donde la transmisión es agudamente estacional. La focalización de SMC depende de una interacción compleja del clima, la transmisión de la malaria y la distribución de la población.
Abdisalan M. Noor, Eliud Kibuchi, Bernard Mitto, Drissa Coulibaly, Ogobara K. Doumbo, Robert W. Snow   +5 more
openaire   +4 more sources

Effect of seasonal malaria chemoprevention on the acquisition of antibodies to Plasmodium falciparum antigens in Ouelessebougou, Mali

Malaria Journal, 2017
Background Seasonal malaria chemoprevention (SMC) is a new strategy to reduce malaria burden in young children in Sahelian countries. It consists of the administration of full treatment courses of sulfadoxine–pyrimethamine plus amodiaquine to children at
Almahamoudou Mahamar, Djibrilla Issiaka, Amadou Barry, Oumar Attaher, Adama B. Dembele, Tiangoua Traore, Adama Sissoko, Sekouba Keita, Bacary Soumana Diarra, David L. Narum, Patrick E. Duffy, Alassane Dicko, Michal Fried   +12 more
doaj   +1 more source

Feasibility and Coverage of Implementing Intermittent Preventive Treatment of Malaria in Pregnant women Contacting Private or Public Clinics in Tanzania: Experience-based Viewpoints of Health Managers in Mkuranga and Mufindi districts. [PDF]

, 2013
Evidence on healthcare managers' experience on operational feasibility of malaria intermittent preventive treatment for malaria during pregnancy (IPTp) using sulphadoxine-pyrimethamine (SP) in Africa is systematically inadequate.
A Hughes, A Vallely, AD Asante, AK Rowe, B Greenwood, C Menendez, C Pell, C Pell, C Quijada, C von Both, E Tambo, E Worrall, EANMAT - East Africa Network for Monitoring Anti-Malarial Treatment, ED Nsimba, EV Mbugi, FM Ringsted, FO ter Kuile, G Hobbs, G Mubyazi, G Mubyazi, G Mubyazi, G Mubyazi, GB Fosu, GM Mubyazi, GM Mubyazi, GM Mubyazi, GM Mubyazi, GM Mubyazi, GM Mubyazi, Godfrey M Mubyazi, H Tagbor, Health Research Action (HERA), J Hill, J Hill, J Hill, J Morse, J Smithson, J Webster, Jens Byskov, K Anders, K Gross, Malaria Consortium - Tanzania, Ministry of Health (MoH) – National Malaria Control Programme, MoH – Tanzania, MS Alilio, Pascal Magnussen, Paul Bloch, President’s Malaria Initiative (PMI), RBM - Roll Back Malaria - Tanzania, RK Yin, S Ugoh, SO Maluka, T Marchant, University of Copenhagen, Denmark, WHO, World Health Organization (WHO),, WP O’Meara   +56 more
core   +1 more source